#BEGIN_DRUGCARD DB01796

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
89-00-9

# ChEBI_ID:
16675

# Chemical_Formula:
C7H5NO4

# Chemical_IUPAC_Name:
pyridine-2,3-dicarboxylic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
A metabolite of tryptophan with a possible role in neurodegenerative disorders. Elevated CSF levels of quinolinic acid are correlated with the severity of neuropsychological deficits in patients who have AIDS. [PubChem]

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
1.1E+004 mg/L (at 25 °C)

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Quinolinic Acid

# HET_ID:
NTM

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C7H5NO4/c9-6(10)4-2-1-3-8-5(4)7(11)12/h1-3H,(H,9,10)(H,11,12)

# InChI_Key:
InChIKey=GJAWHXHKYYXBSV-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C03722

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1796

# Mechanism_Of_Action:
Not Available

# Melting_Point:
228.5 °C

# Molecular_Weight_Avg:
167.1189

# Molecular_Weight_Mono:
167.021857653

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1QAP

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
0.15

# Predicted_LogS:
-1.6

# Predicted_Water_Solubility:
4.07e+00 g/l

# Primary_Accession_No:
DB01796

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
1066

# PubChem_Substance_ID:
46505240

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02391

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC(=O)C1=CC=CN=C1C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:30 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
2.43

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
L07292

# Drug_Target_1_GenBank_ID_Protein:
415621

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
nadC

# Drug_Target_1_Gene_Sequence:
>894 bp
ATGCCGCCTCGCCGTTATAACCCAGACGACCGACGTGACGCGCTACTGGAACGCATTAAT
CTCGATATCCCTGCCGCCGTTGCTCAGGCGCTGCGTGAAGATTTAGGTGGAGAAGTCGAT
GCTGGCAACGATATCACCGCGCAACTTTTGCCGGCAGATACGCAAGCCCATGCCACGGTG
ATCACTCGTGAAGACGGCGTTTTCTGCGGCAAGCGCTGGGTTGAAGAGGTCTTCATCCAA
CTGGCGGGCGATGATGTGCGCCTCACCTGGCATGTCGATGACGGCGACGCCATTCACGCC
AACCAAACAGTGTTTGAACTGAACGGCCCGGCTCGCGTATTGCTGACCGGCGAGCGCACG
GCGCTAAACTTTGTCCAGACCCTTTCCGGCGTCGCCAGTGAAGTACGCCGCTACGTTGGA
CTGTTGGCTGGCACCCAAACCCAGTTGCTCGACACGCGTAAAACGCTGCCGGGTCTGCGC
ACCGCGCTCAAATATGCGGTTTTATGCGGCGGCGGCGCCAATCATCGTCTGGGCCTCACT
GACGCGTTCCTGATTAAAGAAAACCATATTATCGCCTCCGGTTCGGTTCGTCAGGCGGTG
GAAAAAGCGTTCTGGCTACATCCGGACGTGCCGGTAGAAGTCGAGGTCGAAAATCTGGAT
GAACTGGACGATGCGCTGAAAGCAGGCGCGGATATTATCATGCTGGATAATTTCAACACC
GACCAGATGCGCGAGGCGGTGAAACGCGTCAACGGCCAGGCGCGGCTGGAAGTATCCGGC
AACGTCACCGCGGAAACCTTACGCGAATTTGCTGAAACCGGGGTGGATTTCATCTCCGTT
GGCGCGCTGACCAAGCACGTGCGCGCGCTCGATCTCTCCATGCGTTTTTGCTGA

# Drug_Target_1_General_Function:
Coenzyme transport and metabolism

# Drug_Target_1_General_References:
11677609	McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, Hou S, Layman D, Leonard S, Nguyen C, Scott K, Holmes A, Grewal N, Mulvaney E, Ryan E, Sun H, Florea L, Miller W, Stoneking T, Nhan M, Waterston R, Wilson RK: Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature. 2001 Oct 25;413(6858):852-6.
8419294	Hughes KT, Dessen A, Gray JP, Grubmeyer C: The Salmonella typhimurium nadC gene: sequence determination by use of Mud-P22 and purification of quinolinate phosphoribosyltransferase. J Bacteriol. 1993 Jan;175(2):479-86.
9016724	Eads JC, Ozturk D, Wexler TB, Grubmeyer C, Sacchettini JC: A new function for a common fold: the crystal structure of quinolinic acid phosphoribosyltransferase. Structure. 1997 Jan 15;5(1):47-58.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2459

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
32560

# Drug_Target_1_Name:
Nicotinate-nucleotide pyrophosphorylase [carboxylating]

# Drug_Target_1_Number_of_Residues:
297

# Drug_Target_1_PDB_ID:
1QAP

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01729	QRPTase_C
PF02749	QRPTase_N

# Drug_Target_1_Protein_Sequence:
>Nicotinate-nucleotide pyrophosphorylase [carboxylating]
MPPRRYNPDDRRDALLERINLDIPAAVAQALREDLGGEVDAGNDITAQLLPADTQAHATV
ITREDGVFCGKRWVEEVFIQLAGDDVRLTWHVDDGDAIHANQTVFELNGPARVLLTGERT
ALNFVQTLSGVASEVRRYVGLLAGTQTQLLDTRKTLPGLRTALKYAVLCGGGANHRLGLT
DAFLIKENHIIASGSVRQAVEKAFWLHPDVPVEVEVENLDELDDALKAGADIIMLDNFNT
DQMREAVKRVNGQARLEVSGNVTAETLREFAETGVDFISVGALTKHVRALDLSMRFC

# Drug_Target_1_Reaction:
nicotinate D-ribonucleotide + diphosphate + CO2 = pyridine-2,3-dicarboxylate + 5-phospho-alpha-D-ribose 1-diphosphate

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Nicotinate D-ribonucleotide + diphosphate + CO(2) = pyridine-2,3-dicarboxylate + 5-phospho-alpha-D-ribose 1- diphosphate

# Drug_Target_1_SwissProt_ID:
P30012

# Drug_Target_1_SwissProt_Name:
NADC_SALTY

# Drug_Target_1_Synonyms:
EC 2.4.2.19
QAPRTase
Quinolinate phosphoribosyltransferase [decarboxylating]

# Drug_Target_1_Theoretical_pI:
4.73

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
BX842577

# Drug_Target_2_GenBank_ID_Protein:
2117242

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
nadC

# Drug_Target_2_Gene_Sequence:
>858 bp
ATGGGGTTATCCGACTGGGAGCTGGCTGCGGCTCGAGCAGCAATCGCGCGTGGGCTCGAC
GAGGACCTCCGGTACGGCCCGGATGTCACCACATTGGCGACGGTGCCTGCCAGTGCGACG
ACCACCGCATCGCTGGTGACCCGGGAGGCCGGTGTGGTTGCCGGATTGGATGTCGCGCTG
CTGACGCTGAACGAAGTCCTGGGCACCAACGGTTATCGGGTGCTCGACCGCGTCGAGGAC
GGCGCCCGGGTGCCGCCGGGAGAGGCACTTATGACGCTGGAAGCCCAAACGCGCGGATTG
TTGACCGCCGAGCGCACCATGTTGAACCTGGTCGGTCACCTGTCGGGAATCGCCACCGCG
ACGGCCGCGTGGGTCGATGCTGTGCGCGGGACCAAAGCGAAAATCCGCGATACCCGTAAG
ACGCTGCCCGGCCTGCGCGCGCTGCAAAAATACGCGGTGCGTACCGGTGGCGGCGTCAAC
CATCGGCTGGGGTTGGGTGATGCCGCGCTAATCAAGGACAACCACGTTGCCGCCGCCGGA
TCCGTGGTAGACGCGCTACGTGCGGTGCGAAATGCTGCACCCGATCTGCCGTGCGAGGTG
GAAGTGGACTCGCTTGAGCAGCTCGATGCCGTGCTGCCGGAAAAACCCGAGCTGATCCTG
CTGGACAATTTTGCGGTGTGGCAGACGCAGACCGCGGTGCAGCGTCGGGACTCGCGCGCG
CCCACCGTCATGCTGGAGTCATCCGGTGGGCTCAGCCTGCAGACGGCGGCGACCTACGCC
GAAACCGGGGTGGACTACCTGGCGGTCGGGGCGCTCACACACTCAGTGCGCGTGCTCGAC
ATCGGCTTGGATATGTAG

# Drug_Target_2_General_Function:
Coenzyme transport and metabolism

# Drug_Target_2_General_References:
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.
9862811	Sharma V, Grubmeyer C, Sacchettini JC: Crystal structure of quinolinic acid phosphoribosyltransferase from Mmycobacterium tuberculosis: a potential TB drug target. Structure. 1998 Dec 15;6(12):1587-99.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2442

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
29951

# Drug_Target_2_Name:
Nicotinate-nucleotide pyrophosphorylase [carboxylating]

# Drug_Target_2_Number_of_Residues:
285

# Drug_Target_2_PDB_ID:
1QPR

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF01729	QRPTase_C
PF02749	QRPTase_N

# Drug_Target_2_Protein_Sequence:
>Nicotinate-nucleotide pyrophosphorylase [carboxylating]
MGLSDWELAAARAAIARGLDEDLRYGPDVTTLATVPASATTTASLVTREAGVVAGLDVAL
LTLNEVLGTNGYRVLDRVEDGARVPPGEALMTLEAQTRGLLTAERTMLNLVGHLSGIATA
TAAWVDAVRGTKAKIRDTRKTLPGLRALQKYAVRTGGGVNHRLGLGDAALIKDNHVAAAG
SVVDALRAVRNAAPDLPCEVEVDSLEQLDAVLPEKPELILLDNFAVWQTQTAVQRRDSRA
PTVMLESSGGLSLQTAATYAETGVDYLAVGALTHSVRVLDIGLDM

# Drug_Target_2_Reaction:
nicotinate D-ribonucleotide + diphosphate + CO2 = pyridine-2,3-dicarboxylate + 5-phospho-alpha-D-ribose 1-diphosphate

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Nicotinate D-ribonucleotide + diphosphate + CO(2) = pyridine-2,3-dicarboxylate + 5-phospho-alpha-D-ribose 1- diphosphate

# Drug_Target_2_SwissProt_ID:
O06594

# Drug_Target_2_SwissProt_Name:
NADC_MYCTU

# Drug_Target_2_Synonyms:
EC 2.4.2.19
QAPRTase
Quinolinate phosphoribosyltransferase [decarboxylating]

# Drug_Target_2_Theoretical_pI:
4.88

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB01796
